$HELP (Cybin Inc) received 3 mentions from 2 distinct FinTwit voices over the past 12 months, with the first mention appearing on 2026-03-31 and the most recent on 2026-04-20. The most-active voice discussing the stock is @investmentguru_, who mentioned it twice, while @adamfeuerstein contributed one mention. Discussion has centered on $HELP's Phase 3 trials for CYB003 and its UK approval for a second pivotal depression study, positioned within the broader context of psychedelic medicine developments following regulatory catalysts.